The Veteran's claim for increased ratings for post-ablative hypothyroidism (previously classified as Grave's disease) was denied. The Board found that the evidence did not meet the criteria for a rating in excess of 10 percent prior to May 20, 2016 and against entitlement to a rating in excess of 60 percent since that date.
The deciding factor: The preponderance of the evidence did not show symptoms warranting higher ratings based on the conjunctive nature of the Diagnostic Code criteria for increased ratings. The Veteran's heart rate was normal, and she did not report or have diagnosed muscular weakness, cardiovascular involvement, or bradycardia (less than 60 beats per minute).
- Claimed conditions
- Graves' disease, exophthalmos
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- October 24, 2017
- Citation
- 1747481
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 1747481.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has remanded the case due to insufficient medical opinions regarding service connection for Graves' disease and a need for an addendum opinion on the etiology of the condition.
- Whole decision: Remanded (sent back)
The Veteran's hyperthyroidism, including Graves' disease and nodular goiter, is remanded due to the need for a TERA examination. The AOJ failed to provide this examination before issuing the rating decision on appeal.
- Whole decision: Remanded (sent back)
The Board has determined that the VA did not properly consider the Veteran's exposure to toxic substances during service, specifically trichlorethylene (TCH), which could be related to his Graves' disease. As a result, the case is being remanded for further action.
- Whole decision: Granted
An effective date of June 21, 2010, is granted for service connection of dermatitis due to the Veteran's Graves' disease.,A rating in excess of 60 percent for dermatitis from April 15, 2024, is denied.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information. How we handle your email.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.